|
Exosomal Drug Delivery
|
5R44CA221487-02
|
$1,000,000
|
|
SPENCER, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
|
2R42CA203456-02A1
|
$999,501
|
|
MARATHI, UPENDRA
|
7 HILLS PHARMA, LLC
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
5R44CA162629-03
|
$833,374
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia
|
5R44CA221539-02
|
$660,235
|
|
RODGERS, BUEL
|
AAVOGEN, INC.
|
|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-05
|
$941,541
|
$941,541
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-04
|
$1,917,582
|
$1,917,582
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging
|
5R21CA161782-02
|
$199,576
|
$199,576
|
BARROSO, MARGARIDA
|
ALBANY MEDICAL COLLEGE
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Building Research Capacity to Address the Challenge of Non Communicable Diseases and Injuries in Rwanda The GUKORANA Research Center
|
5P20CA210284-02
|
$247,982
|
|
CASTLE, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
5R01CA218429-02
|
$1,347,851
|
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylome characterization of bronchial epithelial projenitor cells
|
5R21CA209436-02
|
$180,130
|
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
|
1R01CA230331-01
|
$670,295
|
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
|
1R01CA230756-01
|
$382,013
|
|
WILL, BRITTA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
OTHER FUNCTIONS - Novel Imaging Agents to Expand the Clinical Toolkit for Cancer
|
N43CO120058-000
|
$249,724
|
$249,724
|
WEISS, RON
|
ARKIVAL TECHNOLOGY CORPORATION
|
|
Proteasome inhibitors for the treatment of solid tumors
|
5R01CA213223-02
|
$356,014
|
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
Improving pathologic nodal staging of resected lung cancer
|
2R01CA172253-06
|
$499,347
|
|
OSAROGIAGBON, RAYMOND
|
BAPTIST MEMORIAL HOSPITAL - TIPTON
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER
|
5U01DK108326-04
|
$190,000
|
|
FISHER, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
5F99CA222736-02
|
$44,524
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecularly guided multimodal theranostics for breast cancer
|
5R01CA151962-03
|
$334,627
|
$669,254
|
JOSHI, AMIT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer
|
5R03CA212816-02
|
$79,250
|
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Risk Stratification for and Early Detection of Liver Cancer
|
1U01CA230997-01
|
$732,726
|
|
KANWAL, FASIHA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
5F32CA221015-02
|
$59,038
|
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$828
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$58,696
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting aberrant promoter DNA methylation for anticancer therapy
|
1R21CA229727-01
|
$182,700
|
|
SHEN, LANLAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
5R03CA215940-02
|
$75,288
|
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-05
|
$510,193
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-05
|
$789,245
|
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Precision Antibody-Based Therapy to Neutralize Epstein-Barr Virus-Associated PTLDs
|
1R21CA232275-01
|
$225,765
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
3U01CA189283-04S1
|
$190,203
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Extracellular Hsp70 and hyperthermia in tumor therapy
|
2R01CA119045-06
|
$329,120
|
$164,560
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Transmembrane Signal Modulation by Hyperthermia
|
5R01CA047407-24
|
$280,220
|
$280,220
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
|
1R01CA229784-01
|
$667,694
|
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulatory role of long noncoding RNAs in normal and cancer cells
|
5R50CA211304-02
|
$261,280
|
|
EBRALIDZE, ALEXANDER
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-08
|
$1,439,566
|
$1,439,566
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-04
|
$688,070
|
$688,070
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
|
1R21CA218960-01A1
|
$228,375
|
|
LIBERMANN, TOWIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-09
|
$2,300,000
|
$69,000
|
McDermott, David
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Radiation - Non Ionizing - Total for this search: $185,027,956
|